<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Koshimizu H</submitter><funding>Takeda Science Foundation</funding><funding>Ministry of Education, Culture, Sports, Science and Technology</funding><pagination>485-495</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8698681</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>41(4)</volume><pubmed_abstract>&lt;h4>Aim&lt;/h4>The striatum, a main component of the basal ganglia, is a critical part of the motor and reward systems of the brain. It consists of GABAergic and cholinergic neurons and receives projections of dopaminergic, glutamatergic, and serotonergic neurons from other brain regions. Brain-derived neurotrophic factor (BDNF) plays multiple roles in the central nervous system, and striatal BDNF has been suggested to be involved in psychiatric and neurodegenerative disorders. However, the transcriptomic impact of BDNF on the striatum remains largely unknown. In the present study, we performed transcriptomic profiling of striatal cells stimulated with BDNF to identify enriched gene sets (GSs) and their novel target genes in vitro.&lt;h4>Methods&lt;/h4>We carried out RNA sequencing (RNA-Seq) of mes</pubmed_abstract><journal>Neuropsychopharmacology reports</journal><pubmed_title>Brain-derived neurotrophic factor predominantly regulates the expression of synapse-related genes in the striatum: Insights from in vitro transcriptomics.</pubmed_title><pmcid>PMC8698681</pmcid><funding_grant_id>18K06865</funding_grant_id><funding_grant_id>22790222</funding_grant_id><funding_grant_id>25430077</funding_grant_id><funding_grant_id>18K07891</funding_grant_id><funding_grant_id>24791111</funding_grant_id><funding_grant_id>26460306</funding_grant_id><funding_grant_id>17K10177</funding_grant_id><funding_grant_id>26461635</funding_grant_id><funding_grant_id>24790228</funding_grant_id><pubmed_authors>Koshimizu H</pubmed_authors><pubmed_authors>Nakajima Y</pubmed_authors><pubmed_authors>Miki T</pubmed_authors><pubmed_authors>Adachi N</pubmed_authors><pubmed_authors>Suzuki S</pubmed_authors><pubmed_authors>Sunagawa M</pubmed_authors><pubmed_authors>Matsuoka H</pubmed_authors><pubmed_authors>Ono J</pubmed_authors><pubmed_authors>Ohta KI</pubmed_authors><pubmed_authors>Kawai A</pubmed_authors></additional><is_claimable>false</is_claimable><name>Brain-derived neurotrophic factor predominantly regulates the expression of synapse-related genes in the striatum: Insights from in vitro transcriptomics.</name><description>&lt;h4>Aim&lt;/h4>The striatum, a main component of the basal ganglia, is a critical part of the motor and reward systems of the brain. It consists of GABAergic and cholinergic neurons and receives projections of dopaminergic, glutamatergic, and serotonergic neurons from other brain regions. Brain-derived neurotrophic factor (BDNF) plays multiple roles in the central nervous system, and striatal BDNF has been suggested to be involved in psychiatric and neurodegenerative disorders. However, the transcriptomic impact of BDNF on the striatum remains largely unknown. In the present study, we performed transcriptomic profiling of striatal cells stimulated with BDNF to identify enriched gene sets (GSs) and their novel target genes in vitro.&lt;h4>Methods&lt;/h4>We carried out RNA sequencing (RNA-Seq) of mes</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Dec</publication><modification>2026-05-07T20:14:13.194Z</modification><creation>2022-02-11T14:48:34.406Z</creation></dates><accession>S-EPMC8698681</accession><cross_references><pubmed>34529365</pubmed><doi>10.1002/npr2.12208</doi></cross_references></HashMap>